Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 6/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.38 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.38 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19257812 | 0.92 | TDP1 (0.52) | PRKCATDP1AR | |
| SCHEMBL77521 | 0.90 | PRKCA (0.59) | PRKCATDP1PRKCEPRKCQPRKCD | |
| SCHEMBL7758874 | 0.90 | PRKCA (0.59) | PRKCATDP1PRKCEPRKCQPRKCD | |
| SCHEMBL7759898 | 0.90 | PRKCA (0.59) | PRKCATDP1PRKCEPRKCQPRKCD | |
| Triacetin SCHEMBL22160048 | 0.88 | PRKCA (0.57) | PRKCATDP1ARPRKCEPRKCQ | |
| SCHEMBL19257809 | 0.87 | PRKCA (0.43) | PRKCATDP1AR | |
| SCHEMBL7758842 | 0.86 | PRKCA (0.47) | PRKCATDP1ARPRKCEPRKCQ | |
| Ethylene Glycol SCHEMBL16612582 | 0.86 | PRKCA (0.56) | PRKCATDP1PRKCEPRKCQPRKCD | |
| Acetic Acid SCHEMBL8675242 | 0.86 | PRKCA (0.56) | PRKCATDP1PRKCEPRKCQPRKCD | |
| SCHEMBL11817899 | 0.84 | TDP1 (0.50) | PRKCATDP1AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170233337-A1 | NON-IONIC AMPHIPHILES AND METHODS OF MAKING THE SAME | ARCHER DANIELS MIDLAND CO (IL) | 2017-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170233337-A1 | NON-IONIC AMPHIPHILES AND METHODS OF MAKING THE SAME | PNLIP, FFAR4, SPTLC2 | PRKCA 1665/4885TDP1 2837/4885AR 2621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.